Navigation Links
Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
Date:1/29/2013

pan>, Revenue Forecast ($m), 2011–2019 40

Figure 29: Thalassemia, Italy, Revenue Forecast ($m), 2011–2019 41

Figure 30: Thalassemia, Spain, Revenue Forecast ($m), 2011–2019 41

Figure 31: Thalassemia, Japan, Revenue Forecast ($m), 2011–2019 42

Figure 32: Thalassemia, Total Market, Average Annual Cost of Therapy, 2011–2019 43

Figure 33: Thalassemia, Total Market, Treatment Usage Pattern 44

Figure 34: Thalassemia, Pipeline, Overview 47

Figure 35: Thalassemia: Pipeline, Phase I Molecule Comparison 49

Figure 36: Thalassemia, Pipeline, Phase II Molecule Comparison 50

Figure 37: Thalassemia, Pipeline by Therapeutic Class 51

Figure 38: Thalassemia, Pipeline by Molecule Type 51

Figure 39: Thalassemia, Pipeline by Mechanism of Action 52

Figure 40: Hereditary Angioedema, Total Market, Revenue Forecast($m), 2011–2019 56

Figure 41: Hereditary Angioedema, US, Revenue Forecast ($m), 2011–2019 57

Figure 42: Hereditary Angioedema, UK, Revenue Forecast ($m), 2011–2019 57

Figure 43: Hereditary Angioedema, France, Revenue Forecast ($m), 2011–2019 58

Figure 44: Hereditary Angioedema, Germany, Revenue Forecast ($m), 2011–2019 58

Figure 45: Hereditary Angioedema, Italy, Revenue Forecast ($m), 2011–2019 59

Figure 46: Hereditary Angioedema, Spain, Revenue Forecast ($m), 2011–2019 59

Figure 47: Hereditary Angioedema, Japan, Revenue Forecast ($m), 2011–2019 60

Figure 48: Hereditary Angioedema, Total Market, Average Annual Cost of Therapy, 2011–2019 61

Figure 49: Hereditary Angioedema, Total Market, Treatment Usage Pattern 62

Figure 50: Hereditary Angioede
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
2. FDA Grants Orphan Drug Status To Morphoteks Amatuximab (MORAb-009)
3. Albireo Has Been Granted Orphan Drug Designation for A4250 from the US FDA for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and for Primary Biliary Cirrhosis (PBC)
4. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
5. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
6. Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
7. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
8. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
9. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
10. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
11. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... , Nov. 28, 2014 According to MedlinePlus, ... the course of their lifetime. For many, these pains are ... that is caused by a variety of factors. For those ... may be the best option. While there are a variety ... performed by Seyed M. Rezaian , M.D., Ph.D., F.R.C.S., ...
(Date:11/28/2014)... LAVAL, QC , Nov. 28, 2014 /CNW Telbec/ ... to announce the appointment of Mrs. Dominique Boudreau ... among its management team. Mrs. Dominique Boudreau ... January 2013 and occupied similar duties for more than ... the Ergioresearch Ltd in January 2013.  Mrs. Boudreau replaces ...
(Date:11/28/2014)... 2014  (Booth #7309, North Hall) — Dicom ... product, DCMSYS Interface WebBridge, at the 100th annual RSNA ... Place, Chicago, Illinois . ... Designed for medical facilities of any size, WebBridge allows ... any non-standard data (e.g. JPEG, TFF, PDF, TXT, etc.) ...
Breaking Medicine Technology:4 Advantages of Laser Back Surgery When Fixing a Herniated Disk 2Ergoresearch announces the appointment of its new Vice Président Finance 2Ergoresearch announces the appointment of its new Vice Président Finance 3Dicom Systems Announces WebBridge Interface at RSNA 2014 2
... AHMEDABAD, India , June 21, 2010 ... healthcare companies has,received Phase I clinical trial permission from the DCGI for ... Centre using a,unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule. ... ...
... Ontario , June 18 CardioGenics Holdings Inc. ... Point-Of-Care (POC) analyzer and products for the immunoassay segment of ... filed a Certificate of Change with the Secretary of ... the Company,s authorized and outstanding common stock on a ten ...
Cached Medicine Technology:Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 2Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 3CardioGenics Announces Reverse Stock Split 2CardioGenics Announces Reverse Stock Split 3
(Date:11/28/2014)... 29, 2014 Somax Performance Institute ... measuring and improving sports performance, is pleased to ... surpassed 3,000,00 views. The Institute, which works with ... improves performance far beyond conventional coaching and training ... Microfiber Reduction. , Many viewers have praised the ...
(Date:11/28/2014)... iFitDress.com is a renowned women’s dress company. ... special occasion gowns for the global clients. Recently, iFitDress.com ... in its online store. The new products are now ... According to the sales manager of the company, the ... popular in the international market. , “We are ...
(Date:11/28/2014)... 2014 The report “Poxvirus Infections ... the therapeutic development for Poxvirus Infections, complete with ... drug target, mechanism of action (MoA), route of ... updates, and featured news and press releases. It ... development for Poxvirus Infections and special features on ...
(Date:11/28/2014)... Recently, SWAccessControl.com, a renowned smartware manufacturer, has announced its ... high end products are offered at discounted rates, up ... from today to Dec 16, 2014. , The company’s ... promotion. We are proud of our new access control ... about our hottest items, we have listed some of ...
(Date:11/28/2014)... The clinic is known for ... Neuromuscular Stabilization, Extracorporeal Shock Wave Therapy, computer assisted ... upgraded facilities in 2011, the clinic unveiled their ... Lev Kalika has launched the most advanced and ... the country. , The new lab allows Dr. ...
Breaking Medicine News(10 mins):Health News:Somax Sports Motion Analysis Videos Surpass 3,000,000 Views 2Health News:Somax Sports Motion Analysis Videos Surpass 3,000,000 Views 3Health News:Discounted Teal Cocktail Dresses From Famous Dress Supplier iFitDress.com 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:New Access Control Systems Now Offered At Low Prices By Smartware Manufacturer SWAccessControl.com 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 3
... become as simple as administering stem cell products through an ... therapy can help regenerate damaged heart muscle in patients who ... new study. ,The distinct advantage of the procedure ... from the bone marrow of a healthy donor can reverse ...
... The Indian Institute of Technology (IIT) Delhi has developed a ... country's nine million blind population. // ,Called "smart ... commute in city buses, walk inside a room without knocking ... an emergency. ,The technology has been developed by ...
... new study that analyses many trials together concludes that HRT ... age 60 but has mixed results for older women. // ... (HRT) may prevent heart attacks in women under 60.,The statistical ... done by researchers from Cornell and Stanford universities, is published ...
... India a foundation set up by the Bill and ... as its HIV-AIDS ambassador in India. // The officials ... awareness of the disease in the country.,The official release ... India's HIV disease is a welcomed step in reducing ...
... a lot of attention and HIV/AIDS activists are worried that ... disease.// ,Glenn Betteridge of the Canadian HIV/AIDS Legal ... only serve to increase a false sense of security among ... stigmatize all people living with HIV," Betteridge said "It ...
... serious accidents or injury due to some other cause like ... persons in the emergency room are the same.// However, the ... and could possibly determine the life and death of the ... set of guidelines to treat severely injured patients so that ...
Cached Medicine News:Health News:Stem Cell Therapy Regenerates Heart Muscle In Heart Attack Patients 2Health News:Hi-tech Walking Stick Developed For Visually Impaired 2Health News:Hormone Replacement Therapy Can Reduce Heart attacks On Woman Under 60 2Health News:Guidelines For Treating Severely Injured Patients On The Anvil 2
... An enzyme linked ... the detection and semiquantitation ... (GBM) antibodies in human ... GBM antibodies can be ...
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
Rheumatoid factor screening...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) IgA isotype in human serum....
Medicine Products: